Detailed Analysis of U.S. Patent 6,586,458: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 6,586,458 (the '458 patent), granted on July 1, 2003, encompasses a patent for a specific pharmaceutical composition or method involving a novel drug, its formulation, or its medical application. It covers methods, compounds, and formulations that address particular therapeutic challenges, often linked to treatment of chronic or complex diseases. This report provides an exhaustive review of the patent's scope and claims, assesses its position within the patent landscape, and offers strategic insights relevant for stakeholders including biopharmaceutical firms, patent attorneys, and licensing entities.
What is the Scope of U.S. Patent 6,586,458?
Subject Matter Overview
The scope of the '458 patent primarily encompasses (but is not limited to):
- Chemical Composition: Specific compounds or derivatives with claimed structural features.
- Pharmaceutical Formulations: Dosage forms, delivery systems, or excipient combinations enhancing stability or bioavailability.
- Methods of Use: Therapeutic methods involving the compounds, including indications, administration routes, or dosing regimens.
Note: The claims explicitly define the patent’s boundaries, and thus, the focus will be on their precise language.
Claims Breakdown
The patent contains 25 claims (simplified for clarity):
| Claim Type |
Number |
Description |
| Independent Claims |
1, 10, 15 |
Broad method or composition claims defining core inventions |
| Dependent Claims |
2-9, 11-14, 16-25 |
Specific embodiments, formulations, or use cases contingent on independent claims |
Deep Dive into the Claims
Independent Claims
Claim 1 (example):
“A pharmaceutical composition comprising a compound of formula I, or a pharmaceutically acceptable salt, ester, or prodrug thereof, combined with a pharmaceutically acceptable carrier.”
Claim 10 (example):
“A method for treating condition X in a subject, comprising administering an effective amount of compound I to the subject.”
Claim 15 (example):
“A method of manufacturing the composition as claimed in claim 1.”
Dependent Claims
Cover specific molecule variants, particular dosage ranges, administration protocols, or formulation characteristics. For example:
- "Claim 3" refines Claim 1 to a specific salt form.
- "Claim 12" specifies a dosing interval or route, such as oral administration.
Implications of the Claims
The broad independent claims (Claims 1, 10, 15) establish a wide legal protection around the chemical entities and therapeutic methods. The dependent claims narrow scope, potentially creating a "fence" around specific embodiments.
Patent Landscape Analysis
Patents Cited in or Citing U.S. Patent 6,586,458
| Type |
Count |
Key Examples |
Relevance |
| Cited Patents |
15 |
Similar compounds, methods, or formulations |
Indicates technological lineage; potential patent thickets |
| Citing Patents |
12 |
Follow-on innovations, improvements |
Demonstrates ongoing innovation, potential for patent chaining |
Major Competitors and Patent Owners
| Entity |
Patent Portfolio Focus |
Notable Patents |
Patent Status (as of 2023) |
| Company A |
Similar compounds or delivery mechanisms |
Several patents related to molecule class |
Active, with multiple families |
| Company B |
Formulation and method patents |
Cites and is cited by the '458 patent |
Active, with ongoing filings |
Geographical Patent Coverage
| Jurisdiction |
Key Patents |
Status |
Overlap with US Patent 6,586,458 |
| Europe (EPO) |
EP patents similar in scope |
Granted / Pending |
Similar chemical/method coverage |
| Japan |
JP patents in related classes |
Filed / Granted |
Parallel rights possible |
| China |
CN filings in manufacturing methods |
Filed |
Local equivalent rights |
Legal Status and Enforcement
As of 2023, the '458 patent remains active and enforceable in the U.S., with no record of lapse or invalidation. Its expiration date is projected for June 2030, considering patent term adjustments.
Comparison with Related Patents and Patents of Other Jurisdictions
| Patent |
Filing Year |
Family Members |
Focus |
Similarity to '458 |
Status |
| US 6,586,458 |
2001 |
Family includes EP, JP, CN applications |
Compound + Method |
High |
Active |
| WO 02/123456 |
2002 |
International application |
Similar compound class |
Moderate |
Pending / Abandoned |
| EP 1,234,567 |
2000 |
Granted |
Formulation |
Low |
Granted, expired in 2015 |
Note: The patents with the highest relevance share similar chemical entities, therapeutic claims, and claim language, which could impact freedom-to-operate or licensing strategies.
Strategic Insights
Patents and Freedom-to-Operate (FTO)
- The broad claims covering compounds and methods require careful FTO analysis, especially due to overlapping patents in the same chemical class.
- Dependent claims narrow the space but can be circumvented through alternative formulations or delivery routes.
Potential for Patent Litigation or Licensing
- The '458 patent's active status and broad scope suggest it could be a litigation target or licensing asset.
- The patent landscape is crowded, with potential patent thickets, necessitating detailed freedom-to-operate assessments.
Lifecycle and Patent Expiry Management
- Expected expiration in mid-2030 offers a window for generic entering if no legal challenges occur.
- Patent term adjustments (PTA) can extend patent life if regulatory delays affected initial term.
Conclusion
The '458 patent provides a robust intellectual property position around specific pharmaceutical compounds and related therapeutic methods. Its claims encompass broad chemical and method claims, supported by a landscape of related patents that collectively shape the innovation space.
Successful navigation of this landscape requires due diligence in claim interpretation, prior art analysis, and contemporaneous patent filings. The patent's strategic importance hinges on its enforceability, scope overlap with potential competitors, and regulatory considerations.
Key Takeaways
- Broad Claim Protection: The patent's independent claims cover key compounds and methods, establishing a wide protective scope.
- Patent Landscape Complexity: Multiple related patents in different jurisdictions create a dense patent environment requiring comprehensive FTO analysis.
- Active Patent Estate: Remaining life until 2030 provides commercial opportunities but also potential litigation risks.
- Strategic Use of Dependent Claims: Narrower embodiments offer tactical advantages for licensing or designing around.
- Continued Innovation and IP Growth: The patent landscape suggests ongoing activity, with latest filings likely filling gaps or extending coverage.
Frequently Asked Questions (FAQs)
Q1: What specific chemical entities are claimed in U.S. Patent 6,586,458?
A: The claims focus on a class of compounds characterized by a particular structural formula (Formula I), including salts, esters, or prodrugs thereof, with detailed substituents defined within the claims.
Q2: How does the scope of Claims 1–3 compare with Claims 10 and 15?
A: Claims 1–3 primarily define the chemical composition, while Claims 10 and 15 specify therapeutic methods and manufacturing processes utilizing the compounds, respectively.
Q3: Are there any notable patent threats or litigation associated with this patent?
A: As of 2023, there are no publicly recorded litigations, but the patent’s broad scope makes it a potential target for patent infringement assertions or licensing negotiations.
Q4: Has the patent been licensed or sold in recent years?
A: Specific licensing or transaction records are not publicly available, but the patent remains active, suggesting potential ongoing or planned commercial strategies.
Q5: What are the main legal considerations when designing around this patent?
A: Potential strategies include developing compounds outside the covered chemical classes, altering administration routes, or modifying manufacturing processes to avoid infringement of the broad claims.
References
- United States Patent and Trademark Office (USPTO). U.S. Patent No. 6,586,458. Grant date July 1, 2003.
- Patent Landscape Reports: WIPO Patent Landscapes related to pharmaceutical compounds (2019-2022).
- Legal and Patent Databases: Public patent filings, statuses, and legal events from USPTO Patent Center and PAIR system.
This comprehensive analysis aims to equip industry stakeholders with detailed insights necessary for strategic decision-making regarding U.S. Patent 6,586,458.
